Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 13.45%. However, over the past six months, we’ve seen a stronger performance of -1.84%. The price of IDXX fallen by 13.45% over the last 30 days. And in the last five days, it has surged by 9.71%.
Idexx Laboratories, Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $583.39 on 03/01/24, and the lowest price during the same period was recorded at $398.50 on 11/21/24.
52-week price history of IDXX Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Idexx Laboratories, Inc’s current trading price is -19.60% away from its 52-week high, while its distance from the 52-week low is 17.70%. The stock’s price range for this period has been between $398.50 and $583.39. The Healthcare sector company’s shares saw a trading volume of about 1.51 million for the day, which was higher than the average daily volume of 0.65 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Idexx Laboratories, Inc (IDXX) has experienced a quarterly rise of 3.98% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 38.41B and boasts a workforce of 11000 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 446.01, with a change in price of -11.30. Similarly, Idexx Laboratories, Inc recorded 616,313 in trading volume during the last 100 days, posting a change of -2.35%.
IDXX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for IDXX stands at 0.62. Similarly, the long-term debt-to-equity ratio is also 0.39.
IDXX Stock Stochastic Average
As of today, the raw stochastic average of Idexx Laboratories, Inc over the past 50 days is 92.61%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 91.83%. Additionally, the Stochastic %K and %D values for the company were 66.65% and 53.74%, respectively, over the past 20 days.
